Carving a way forward for CBD and other cannabinoids

Are you confused about the status of CBD and other non-psychotropic cannabinoids in the UK and EU? If you are, you’re not alone. An article by ANH founder, Rob Verkerk PhD and two other experts, just published in New Food magazine sheds light on the subject and explores the regulatory future for the use of CBD and other cannabinoids. 

The article, entitled ‘Carving a way forward for CBD and other non-psychotropic cannabinoids’ co-authored by Rob Verkerk, Parveen Bhatarah PhD from the Centre of Medicinal Cannabis and Association for the Cannabinoid Industry along with Ignazio Garaguso PhD of PerkinElmer Inc, can be accessed in full from the link below

>>> Read the full article at the New Food magazine website.

Plant compounds that speak our language

The case of Charlotte Figi and news in 2013 of the ability of a low-THC, full spectrum CBD extract (later branded as Charlotte’s Web) to quell her severe and rare form of epilepsy triggered the extraordinary and unprecedented growth of the CBD market. Despite Charlotte’s tragic passing aged 13 in April 2020 from pneumonia and suspected covid-19 (although testing negative), her legacy lives on.